Additionally, anti-CD47 mAbs enabled human peripheral blood-derived macrophages to phagocytose patient-derived glioblastoma neurospheres in vitro, which was corroborated by decreased tumor growth in an intracranial xenograft model of glioblastoma [12]. This evidence concerns the gene CD47 and neoplasm.